Ajanta Pharma net profit rises 64 percent to Rs 177 crore in Q3
New Delhi: Drug firm Ajanta Pharma on Tuesday reported a 64 percent rise in its consolidated net profit to Rs 177 crore for the quarter ended December mainly on account of robust sales.The company had posted a net profit of Rs 108 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a BSE filing.Read also: Sun Pharma net profit doubles to Rs 1,852 crore...
New Delhi: Drug firm Ajanta Pharma on Tuesday reported a 64 percent rise in its consolidated net profit to Rs 177 crore for the quarter ended December mainly on account of robust sales.
The company had posted a net profit of Rs 108 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a BSE filing.
Read also: Sun Pharma net profit doubles to Rs 1,852 crore in Q3
Consolidated revenue from operations of the company stood at Rs 749 crore for the quarter under consideration. It was Rs 651 crore for the same period a year ago, it added.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd